Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CQS in Platinum-Refractory Small Cell Lung Cancer
NCT00008372Phase 2Completed
- Sponsor
- City of Hope
- Start
- Dec 2000
- Primary completion
- Sep 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of chlorsulfaquinoxaline in small cell lung cancer (SCLC), sponsored by City of Hope. Started Dec 2000; status: completed.
02
Drugs
chlorsulfaquinoxaline
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00008372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008372.